Immobilization induced hypercalcemia
| dc.contributor.author | Khan, Irfan Iqbal | |
| dc.contributor.author | Ahmad, Waqar | |
| dc.contributor.author | Tahir, Chohan Muhammad | |
| dc.contributor.author | ETAL. | |
| dc.date.accessioned | 2022-02-07T08:29:45Z | |
| dc.date.accessioned | 2023-08-19T08:49:05Z | |
| dc.date.available | 2022-02-07T08:29:45Z | |
| dc.date.available | 2023-08-19T08:49:05Z | |
| dc.date.issued | 2021-11 | |
| dc.description.abstract | Discussion: Albright described immobilization-associated hypercalcemia in 1941. Hypercalcemia immobilization should be accounted for in patients with immobilization and hypercalcemia. It requires extensive evaluation to rule out other more likely hypercalcemia causes. The patients with sepsis or with reduced Glomerular filtration rate are at increased risk. | en_US |
| dc.identifier.citation | Khan, I. I., Ahmad, W., Tahir, C. M., Dhakshinamoorthy, B., & Nag, S. (2021, October). Immobilization induced hypercalcemia. In Endocrine Abstracts (Vol. 77). Bioscientifica. | en_US |
| dc.identifier.doi | http://doi.org/10.1530/endoabs.77.P158 | en |
| dc.identifier.uri | https://edms.wexl.in/handle/1/2498 | |
| dc.language.iso | en | en_US |
| dc.publisher | Endocrine Abstracts | en_US |
| dc.subject | Immobilization | en_US |
| dc.subject | Hypercalcemia | en_US |
| dc.title | Immobilization induced hypercalcemia | en_US |
| dc.title.alternative | Society for Endocrinology BES 2021 | en_US |
| dc.title.alternative | Bioscientifica | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
